AA
AONC

Ancora Advisors’s American Oncology Network, Inc. Class A Common Stock AONC Stock Holding History

Ancora Advisors’s Portfolio AONC Stock Details AONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-120,240
Closed -$1.21M – 2106
2022
Q4 		$1.21M Hold
120,240
– – 0.03% 326
2022
Q3 		$1.18M Hold
120,240
– – 0.04% 327
2022
Q2 		$1.18M Hold
120,240
– – 0.03% 339
2022
Q1 		$1.17M Buy
120,240
+2,000
+2% +$19.4K 0.03% 368
2021
Q4 		$1.15M Hold
118,240
– – 0.03% 366
2021
Q3 		$1.15M Buy
118,240
+1,100
+0.9% +$10.7K 0.03% 363
2021
Q2 		$1.14M Buy
+117,140
New +$1.15M 0.03% 375

Other funds holding AONC

CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return
SCM
Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return
AIMCA
Alberta Investment Management Corp (AIMCo) Edmonton, Alberta, Canada $16.7B AUM 23.27% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
FTCM
Fir Tree Capital Management New York $21.8M AUM 1.61% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.71B AUM 64.83% 1-Year Est. Return
KIM
Karpus Investment Management Pittsford, New York $3.21B AUM 6.83% 1-Year Est. Return
MSU
Mizuho Securities USA New York $4.24B AUM 22.54% 1-Year Est. Return

Ancora Advisors's AONC Position: Q1 2023 in Review

Ancora Advisors sold out of American Oncology Network, Inc. Class A Common Stock (AONC) in Q1 2023, closing a stake of 120,240 shares — an estimated $1.21M sold.

Ancora Advisors first reported a position in AONC in Q2 2021 and held it in 7 quarters. The position peaked at $1.21M in Q4 2022. 13 funds tracked by Wall St. Rank hold AONC as of Q1 2023.

  • Ancora Advisors reported no remaining American Oncology Network, Inc. Class A Common Stock position as of Q1 2023 after selling out during the quarter.
  • Ancora Advisors sold 120,240 American Oncology Network, Inc. Class A Common Stock shares in Q1 2023, an estimated $1.21M.
  • Ancora Advisors first reported a position in American Oncology Network, Inc. Class A Common Stock in Q2 2021 and held it in 7 quarters.
  • Ancora Advisors's American Oncology Network, Inc. Class A Common Stock position peaked at $1.21M in Q4 2022.
  • 13 funds tracked by Wall St. Rank held American Oncology Network, Inc. Class A Common Stock as of Q1 2023.

Based on Ancora Advisors's 13F filing for Q1 2023, filed 16 May 2023.